Loading
AP
Acacia Pharma Group Stock: price and insider trades · Belgium
No insider purchase over the last 90 days. The latest was filed 22 Mar 2022.
Acacia Pharma Group: what insiders have been doing
Acacia Pharma Group belongs to the Health Care sector. Filings by its managers are published through FSMA. No insider at Acacia Pharma Group has published a filing in the past twelve months. The most recent one dates from 22 March 2022.
Our records for Acacia Pharma Group go back to 2021, with 13 purchases and no sales on the open market in total.
Other companies in the same sector with recent insider buying flagged by our signals: Cooper Companies, Inc. and Cytosorbents Corp. This summary is built from FSMA disclosures alone and does not predict where the share price will go.
Insider Decl.
14
Thresholds
n/a
Buy Volume
€92,527
13 ops. · all time
Sell Volume
n/a
n/a
Last declaration on 22 March 2022
Declarations14 total
63,710 shares0ShareEuronext BrusselsISIN GB00BYWF9Y76FSMA:acacia-pharma-group-16
Canonical exit: 13 Jun 2022 (T+90)
5,062 shares@ €1.2934.0% of flowShareEuronext BrusselsISIN GB00BYWF9Y76FSMA:acacia-pharma-group-13
Canonical exit: 29 Mar 2022 (T+90)
5,001 shares@ €1.2933.8% of flowShareEuronext BrusselsISIN GB00BYWF9Y76FSMA:acacia-pharma-group-12
Canonical exit: 29 Mar 2022 (T+90)
5,001 shares@ €1.2935.4% of flowShareEuronext BrusselsISIN GB00BYWF9Y76FSMA:acacia-pharma-group-15
Canonical exit: 29 Mar 2022 (T+90)
5,001 shares@ €1.2933.8% of flowShareEuronext BrusselsISIN GB00BYWF9Y76FSMA:acacia-pharma-group-14
Canonical exit: 29 Mar 2022 (T+90)
3,510 shares@ €1.8332.3% of flowShareEuronext BrusselsISIN GB00BYWF9Y76FSMA:acacia-pharma-group-9
Canonical exit: 6 Jan 2022 (T+90)
3,168 shares@ €2.0330.7% of flowShareEuronext BrusselsISIN GB00BYWF9Y76FSMA:acacia-pharma-group-10
Canonical exit: 28 Sept 2021 (T+90)
3,510 shares@ €1.8332.4% of flowShareEuronext BrusselsISIN GB00BYWF9Y76FSMA:acacia-pharma-group-8
Canonical exit: 6 Jan 2022 (T+90)
3,510 shares@ €1.8332.4% of flowShareEuronext BrusselsISIN GB00BYWF9Y76FSMA:acacia-pharma-group-11
Canonical exit: 6 Jan 2022 (T+90)
3,510 shares@ €1.8334.0% of flowShareEuronext BrusselsISIN GB00BYWF9Y76FSMA:acacia-pharma-group-7
Canonical exit: 6 Jan 2022 (T+90)
235,829 shares@ €0.10100.0% of flowOptions /warrants for employees or managersOtherISIN GB00BYWF9Y76FSMA:acacia-pharma-group-4
Canonical exit: 6 Oct 2021 (T+90)
3,168 shares@ €2.0333.8% of flowShareEuronext BrusselsISIN GB00BYWF9Y76FSMA:acacia-pharma-group-5
Canonical exit: 28 Sept 2021 (T+90)
3,168 shares@ €2.0333.8% of flowShareEuronext BrusselsISIN GB00BYWF9Y76FSMA:acacia-pharma-group-6
Canonical exit: 28 Sept 2021 (T+90)
3,168 shares@ €2.0333.7% of flowShareEuronext BrusselsISIN GB00BYWF9Y76FSMA:acacia-pharma-group-3
Canonical exit: 28 Sept 2021 (T+90)
14 of 14 declarations
About Acacia Pharma Group
Acacia Pharma Group is a company focused on developing treatments for patients undergoing surgical procedures. It is listed on the XBRU market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
